In mice, the restriction of calpain-1 and calpain-2 activities by using a cardiomyocyte-specific deletion of the common subunit Capn4 or by overexpressing calpastatin reduced adverse-post-infarction remodeling and mortality [89,96,97]. The gene discussed is CAST; the disease is infarction.